Your browser doesn't support javascript.
loading
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis.
Foley, Éimear M; Griffiths, Sian Lowri; Murray, Alexander; Rogers, Jack; Corsi-Zuelli, Fabiana; Hickinbotham, Hannah; Warwick, Ella; Wilson, Martin; Kaser, Muzaffer; Murray, Graham K; Deakin, Bill; Jadon, Deepak; Suckling, John; Barnes, Nicholas M; Upthegrove, Rachel; Khandaker, Golam M.
Afiliación
  • Foley ÉM; MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Griffiths SL; Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Murray A; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
  • Rogers J; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
  • Corsi-Zuelli F; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
  • Hickinbotham H; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
  • Warwick E; Department of Neuroscience and Behaviour, Division of Psychiatry, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Wilson M; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Kaser M; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Murray GK; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
  • Deakin B; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
  • Jadon D; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Suckling J; Cambridgeshire and Peterborough NHS Foundation Trust, Fulbourn, UK.
  • Barnes NM; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Upthegrove R; Cambridgeshire and Peterborough NHS Foundation Trust, Fulbourn, UK.
  • Khandaker GM; Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
BMJ Open ; 13(3): e067944, 2023 03 24.
Article en En | MEDLINE | ID: mdl-36963796
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Interleucina-6 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Interleucina-6 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido